Published in Immunology on December 01, 2001
Immunosenescence and macrophage functional plasticity: dysregulation of macrophage function by age-associated microenvironmental changes. Immunol Rev (2005) 1.64
Infection, inflammation and exercise in cystic fibrosis. Respir Res (2013) 0.91
Crohn's disease as an immunodeficiency. Expert Rev Clin Immunol (2010) 0.89
Exhaustive exercise reduces TNF-α and IFN-α production in response to R-848 via toll-like receptor 7 in mice. Eur J Appl Physiol (2010) 0.78
Divergent neuroendocrine responses to localized and systemic inflammation. Semin Immunol (2014) 0.76
Epinephrine is associated with both erectile dysfunction and lower urinary tract symptoms. Fertil Steril (2008) 0.75
Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. Anal Biochem (1982) 27.26
Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science (1985) 19.41
IL-10 inhibits cytokine production by activated macrophages. J Immunol (1991) 13.13
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell (1993) 9.84
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Deactivation of macrophages by transforming growth factor-beta. Nature (1988) 5.56
Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med (1993) 5.46
Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med (1993) 4.30
Interleukin-12 is required for interferon-gamma production and lethality in lipopolysaccharide-induced shock in mice. Eur J Immunol (1995) 3.76
Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg (1992) 2.96
Immune-neuro-endocrine interactions: facts and hypotheses. Endocr Rev (1996) 2.78
Evidence for the involvement of interleukin 10 in the differential deactivation of murine peritoneal macrophages by prostaglandin E2. J Exp Med (1994) 2.69
Balance of inflammatory cytokines related to severity and mortality of murine sepsis. Infect Immun (1996) 2.43
Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun (1993) 2.10
Interleukin-10 (IL-10) inhibits the induction of nitric oxide synthase by interferon-gamma in murine macrophages. Biochem Biophys Res Commun (1992) 2.08
Adrenergic receptors as models for G protein-coupled receptors. Annu Rev Neurosci (1992) 2.04
Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest (1996) 1.99
Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest (1997) 1.94
Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol (1994) 1.92
Norepinephrine accelerates HIV replication via protein kinase A-dependent effects on cytokine production. J Immunol (1998) 1.90
Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol (1995) 1.81
Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology (1994) 1.55
Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol (1995) 1.53
Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun (1995) 1.45
Anti-inflammatory activities of cAMP-elevating agents: enhancement of IL-10 synthesis and concurrent suppression of TNF production. J Leukoc Biol (1998) 1.30
Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. J Clin Invest (1995) 1.17
Epinephrine inhibits endotoxin-induced IL-1 beta production: roles of tumor necrosis factor-alpha and IL-10. Am J Physiol (1997) 1.12
Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol (1995) 1.06
Isoproterenol regulates tumour necrosis factor, interleukin-10, interleukin-6 and nitric oxide production and protects against the development of vascular hyporeactivity in endotoxaemia. Immunology (1997) 0.99
Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol (1996) 0.99
The beta2-adrenergic agonist salbutamol is a potent suppressor of established collagen-induced arthritis: mechanisms of action. J Immunol (1999) 0.93
Isoproterenol inhibits Il-10, TNF-alpha, and nitric oxide production in RAW 264.7 macrophages. Brain Res Bull (1998) 0.93
Lipopolysaccharide-induced interleukin 8 production by human whole blood is enhanced by epinephrine and inhibited by hydrocortisone. Infect Immun (1997) 0.93
Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. Biochem Biophys Res Commun (1993) 0.91
Gamma-interferon restores listericidal activity and concurrently enhances release of reactive oxygen metabolites in dexamethasone-treated human monocytes. J Clin Invest (1988) 0.89
Adrenaline inhibits macrophage nitric oxide production through beta1 and beta2 adrenergic receptors. Immunology (2000) 0.86
Regulation of interleukin-10 production by beta-adrenergic agonists. Eur J Immunol (1996) 0.85
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol (2001) 2.70
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol (1981) 2.50
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41
Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A (1981) 2.31
Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun (2001) 2.21
Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol (1992) 2.16
Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect Immun (1992) 1.55
Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect Immun (2006) 1.54
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun (1991) 1.54
Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals No essential role for the protein in the growth and virulence of Mycobacterium intracellulare. Infect Immun (1998) 1.53
Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun (1995) 1.45
Pathology of Listeria infection in murine severe combined immunodeficiency. A study by immunohistochemistry and electron microscopy. Lab Invest (1988) 1.45
Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int Immunol (1996) 1.44
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun (1992) 1.29
The biology of the SCID mutation. Immunol Today (1989) 1.19
Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun (2001) 1.17
Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol (1994) 1.13
Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect Immun (1996) 1.11
Early nonspecific immune responses and immunity to blood-stage nonlethal Plasmodium yoelii malaria. Infect Immun (2000) 1.07
Production of interferons during experimental African trypanosomiasis. Clin Exp Immunol (1983) 1.07
T cell-independent macrophage activation in scid mice. Curr Top Microbiol Immunol (1989) 1.03
Gut intraepithelial lymphocytes induce immunity against Cryptosporidium infection through a mechanism involving gamma interferon production. Infect Immun (1997) 0.99
Cytokine and chemokine responses following pulmonary challenge with Aspergillus fumigatus: obligatory role of TNF-alpha and GM-CSF in neutrophil recruitment. Med Mycol (1999) 0.99
CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans. Immunology (1997) 0.99
Administration of interleukin-10 abolishes innate resistance to Listeria monocytogenes. Eur J Immunol (1996) 0.99
Modulation of murine macrophage behavior in vivo and in vitro. Methods Cell Biol (1994) 0.98
Cryptosporidium muris in adult mice: adoptive transfer of immunity and protective roles of CD4 versus CD8 cells. Infect Immun (1994) 0.98
Interferon-gamma mediates host resistance in a murine model of melioidosis. Biochem Soc Trans (1997) 0.91
Effect of variation in environmental temperature on blood pressure: is it important? Cent Afr J Med (1998) 0.90
Relationship between bladder cancer incidence, Schistosoma haematobium infection, and geographical region in Zimbabwe. Trans R Soc Trop Med Hyg (1991) 0.90
Interaction of African trypanosomes with the immune system. Philos Trans R Soc Lond B Biol Sci (1984) 0.87
Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression. Infect Immun (1985) 0.85
Resolution of cryptosporidial infection in mice correlates with parasite-specific lymphocyte proliferation associated with both Th1 and Th2 cytokine secretion. Parasite Immunol (1995) 0.83
Cryptosporidium infection in major histocompatibility complex congeneic strains of mice: variation in susceptibility and the role of T-cell cytokine responses. Parasitol Res (1997) 0.82
In vivo analysis of immune responses to Cryptococcus neoformans--role of interferon-gamma in host resistance. Biochem Soc Trans (1997) 0.79
Immunological control of Cryptosporidium infection. Chem Immunol (1998) 0.79
Aspects of insulin resistance in urbanisation-related hypertension in Zimbabwe: a preliminary report. J Hum Hypertens (1994) 0.78
Antigen processing and presentation: modelling with Leishmania. Behring Inst Mitt (1991) 0.77
African neutropaenia in Zimbabwe. Cent Afr J Med (1994) 0.75